| __timestamp | Celldex Therapeutics, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3586000 | 122045000 |
| Thursday, January 1, 2015 | 5480000 | 144427000 |
| Friday, January 1, 2016 | 6786000 | 215003000 |
| Sunday, January 1, 2017 | 12743000 | 302238000 |
| Monday, January 1, 2018 | 9538000 | 408897000 |
| Tuesday, January 1, 2019 | 3573000 | 392755000 |
| Wednesday, January 1, 2020 | 7418000 | 520397000 |
| Friday, January 1, 2021 | 4651000 | 579775000 |
| Saturday, January 1, 2022 | 2357000 | 667238000 |
| Sunday, January 1, 2023 | 6883000 | 607521000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, revenue growth is a key indicator of a company's success. Over the past decade, Supernus Pharmaceuticals, Inc. and Celldex Therapeutics, Inc. have showcased contrasting revenue trajectories. Supernus Pharmaceuticals has consistently outperformed, with a staggering 447% increase in revenue from 2014 to 2023, peaking at over $667 million in 2022. In contrast, Celldex Therapeutics experienced a more volatile journey, with revenue fluctuating significantly, reaching its highest point in 2017 with a 255% increase from 2014, before dipping in subsequent years. This comparison highlights the resilience and strategic prowess of Supernus Pharmaceuticals in maintaining steady growth, while Celldex Therapeutics navigates the challenges of the biotech sector. As the industry evolves, these companies' revenue trends offer valuable insights into their market positioning and future potential.
Breaking Down Revenue Trends: Novo Nordisk A/S vs Celldex Therapeutics, Inc.
Merck & Co., Inc. and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: BioMarin Pharmaceutical Inc. and Celldex Therapeutics, Inc. Performance Compared
Revenue Insights: Catalent, Inc. and Supernus Pharmaceuticals, Inc. Performance Compared
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Celldex Therapeutics, Inc.
Ascendis Pharma A/S and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: PTC Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.
Perrigo Company plc and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
ACADIA Pharmaceuticals Inc. and Celldex Therapeutics, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: HUTCHMED (China) Limited vs Supernus Pharmaceuticals, Inc.
Breaking Down Revenue Trends: ImmunityBio, Inc. vs Supernus Pharmaceuticals, Inc.
Revenue Insights: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc. Performance Compared